StockData
GRAIL, Inc. logo

GRAIL, Inc. (GRAL) stock

GRALNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 10/30
$105.88+0.28 (+0.27%)

Close on Nov 17, 2026Market cap $4.73BP/E –Yield –

Grail operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Grail's operating cash flow for the twelve months ending Jun 30, 2026 was -$294.75M. For fiscal 2025 it was -$299.01M.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$299.01M–
FY2024Dec 31, 2024-$577.16M–
FY2023Dec 31, 2023-$595.80M–
FY2022Jan 1, 2023-$561.31M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$80.73M–
Q1 FY2026Mar 31, 2026-$86.99M–
Q4 FY2025Dec 31, 2025-$63.79M–
Q3 FY2025Sep 30, 2025-$63.25M–
Q2 FY2025Jun 30, 2025-$76.97M–
Q1 FY2025Mar 31, 2025-$95.01M–
Q4 FY2024Dec 31, 2024-$93.49M–
Q3 FY2024Sep 30, 2024-$104.58M–
Q2 FY2024Jun 30, 2024-$171.80M–
Q1 FY2024Mar 31, 2024-$207.29M–
Q4 FY2023Dec 31, 2023-$128.90M–
Q3 FY2023Oct 1, 2023-$157.51M–

More Grail figures

See a number that looks wrong?